Moderna's vaccine trials received funding from CEPI and authorization from Health Canada, with FDA oversight.

The entities involved

• Moderna →

  American biotechnology company

  • Moderna and Merck announced the successful outcome of their Phase 3 combined treatment trials involving a new cancer vaccine and Keytruda.Sun 12:39
  • Merck and Moderna funded an Australian-led clinical trial involving the University of Sydney.Sat 22:35
• Coalition for Epidemic Preparedness Innovations →

  Public-private organization for vaccine development

  • CEPI provided support for the Tumaini trial, where a Merck vaccine is being administered in the Democratic Republic of the Congo.Sat 13:33
• FDA →
  • The illegal U.S. vape market is estimated to be worth $9 billion, fueled by unauthorized imports from China, while products must meet FDA authorization standards.Sun 20:36
  • VDPHL01 and Veradermics, Incorporated are seeking FDA approval for their lead therapies targeting hair loss.Sun 20:31

Related events

• Moderna announced a collaboration with Merck KGaA regarding a personalized cancer vaccine platform.Jun 7
• Moderna presented vaccine results at the ESMO meeting in Madrid, with RBC Capital Markets covering the company.Fri 10:55
• Moderna and Merck announced a partnership on their mRNA cancer vaccine trial, leading to analyst rating hikes.Aug 25
• Moderna, Pfizer, and Merck are part of a healthcare rotation story, with Moderna outperforming Pfizer in current stock gains.Oct 15
• Nasdaq added Moderna to its Nasdaq-100 index, and Moderna combined its vaccine with Merck's drug.Oct 18